Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-20

FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' supplemental application for mirtazapine, allowing a generic version to come to market under the ANDA process. The a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)